These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37650735)

  • 1. Novel diamides inspired by protein kinase inhibitors as anti-
    Vieira da Silva Torchelsen FK; Fernandes Pedrosa TC; Rodrigues MP; de Aguiar AR; de Oliveira FM; Amarante GW; Sales-Junior PA; Branquinho RT; Gomes da Silva SP; Talvani A; Fonseca Murta SM; Martins FT; Braun RL; Teixeira RR; Furtado Mosqueira VC; Lana M
    Future Med Chem; 2023 Aug; 15(16):1469-1489. PubMed ID: 37650735
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
    Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
    Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
    Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S
    Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
    De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
    Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
    Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
    Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
    Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits Trypanosoma cruzi arginine kinase and exerts a trypanocidal activity.
    Valera Vera EA; Sayé M; Reigada C; Damasceno FS; Silber AM; Miranda MR; Pereira CA
    Int J Biol Macromol; 2016 Jun; 87():498-503. PubMed ID: 26976067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
    Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins change the cytokine profile in
    González-Herrera F; Clayton NS; Guzmán-Rivera D; Carrillo I; Castillo C; Catalán M; Anfossi R; Quintero-Pertuz H; Quilaqueo ME; Olea-Azar C; Rivera-Meza M; Kemmerling U; Ridley AJ; Vivar R; Maya JD
    Front Immunol; 2022; 13():1035589. PubMed ID: 36713380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
    Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
    Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment.
    de Albuquerque S; Cianni L; de Vita D; Duque C; Gomes ASM; Gomes P; Laughton C; Leitão A; Montanari CA; Montanari R; Ribeiro JFR; da Silva JS; Teixeira C
    Chem Biol Drug Des; 2020 Sep; 96(3):948-960. PubMed ID: 33058457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
    Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
    Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
    Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid-rich extract presents trypanocidal action in vitro but worsens mice under experimental acute Chagas disease.
    Daga MA; Nicolau ST; Jurumenha-Barreto J; Lima LBS; Cabral IL; Pivotto AP; Stefanello A; Amorim JPA; Hoscheid J; Silva EA; Ayala TS; Menolli RA
    Parasite Immunol; 2023 Oct; 45(10):e13005. PubMed ID: 37467029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Evaluation of Nucleoside Analogues against
    Fiuza LFA; Batista DGJ; Girão RD; Hulpia F; Finamore-Araújo P; Aldfer MM; Elmahallawy EK; De Koning HP; Moreira O; Van Calenbergh S; Soeiro MNC
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.